DK0797987T3 - Granulært præparat med langvarig frigivelse og fremgangsmåde til fremstilling deraf - Google Patents
Granulært præparat med langvarig frigivelse og fremgangsmåde til fremstilling derafInfo
- Publication number
- DK0797987T3 DK0797987T3 DK95940461T DK95940461T DK0797987T3 DK 0797987 T3 DK0797987 T3 DK 0797987T3 DK 95940461 T DK95940461 T DK 95940461T DK 95940461 T DK95940461 T DK 95940461T DK 0797987 T3 DK0797987 T3 DK 0797987T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- sustained
- release
- granular preparations
- release granular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31441494 | 1994-12-19 | ||
PCT/JP1995/002594 WO1996019200A1 (fr) | 1994-12-19 | 1995-12-18 | Preparation granulaire a liberation prolongee et procede de production |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0797987T3 true DK0797987T3 (da) | 2004-02-16 |
Family
ID=18053063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95940461T DK0797987T3 (da) | 1994-12-19 | 1995-12-18 | Granulært præparat med langvarig frigivelse og fremgangsmåde til fremstilling deraf |
Country Status (14)
Country | Link |
---|---|
US (2) | US5858411A (da) |
EP (1) | EP0797987B1 (da) |
JP (1) | JP3893439B2 (da) |
KR (1) | KR100424931B1 (da) |
CN (1) | CN1093758C (da) |
AT (1) | ATE251896T1 (da) |
DE (1) | DE69531957T2 (da) |
DK (1) | DK0797987T3 (da) |
ES (1) | ES2210321T3 (da) |
FI (1) | FI119720B (da) |
NO (1) | NO320356B1 (da) |
PT (1) | PT797987E (da) |
TW (1) | TW406022B (da) |
WO (1) | WO1996019200A1 (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
EP0901786B1 (en) * | 1997-08-11 | 2007-06-13 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
US6632455B2 (en) * | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
DE19820801A1 (de) * | 1998-05-09 | 1999-11-25 | Gruenenthal Gmbh | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
US6579953B1 (en) | 1998-09-30 | 2003-06-17 | Basf Aktiengesellschaft | Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
EP1027885B1 (en) * | 1999-02-09 | 2008-07-09 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
US6316462B1 (en) * | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
GB0003782D0 (en) * | 2000-02-17 | 2000-04-05 | Dumex Ltd As | Process |
JP4310605B2 (ja) * | 2001-05-25 | 2009-08-12 | 大塚製薬株式会社 | 医薬用組成物 |
US20050025825A1 (en) * | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
US20090214644A1 (en) * | 2003-07-31 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
US20090215898A1 (en) | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050245614A1 (en) * | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
WO2006023001A1 (en) * | 2004-07-30 | 2006-03-02 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20060275365A1 (en) * | 2005-06-07 | 2006-12-07 | Thomas Backensfeld | Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof |
US20070059359A1 (en) * | 2005-06-07 | 2007-03-15 | Thomas Backensfeld | Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof |
US20070082048A1 (en) * | 2005-06-08 | 2007-04-12 | Ronald Warner | Sleep aid formulations |
JP4938771B2 (ja) | 2005-06-20 | 2012-05-23 | ゼノポート,インコーポレーテッド | トラネキサム酸のカルバミン酸アシルオキシアルキルプロドラッグ、合成法、および使用 |
US20070036859A1 (en) * | 2005-08-11 | 2007-02-15 | Perry Ronald L | Sustained release antihistamine and decongestant composition |
SI2001445T1 (sl) * | 2006-03-16 | 2015-02-27 | Euro-Celtique S.A. | Farmacevtski sferoidi |
MX2008010233A (es) * | 2008-03-10 | 2009-11-10 | Eurodrug Lab B V | Composicion de liberacion modificada, que comprende doxofilina. |
US20100280117A1 (en) * | 2009-04-30 | 2010-11-04 | Xanodyne Pharmaceuticals, Inc. | Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders |
WO2011091164A1 (en) * | 2010-01-22 | 2011-07-28 | Xenoport, Inc. | Oral dosage forms having a high loading of a tranexamic acid prodrug |
EP2540317A4 (en) * | 2010-02-22 | 2014-04-16 | Daiichi Sankyo Co Ltd | SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION |
GB201010083D0 (en) * | 2010-06-16 | 2010-07-21 | Univ Bradford | Compositions and methods |
KR102286952B1 (ko) * | 2013-12-31 | 2021-08-09 | 롯데정밀화학 주식회사 | 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말 |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
RU2018145364A (ru) | 2016-06-27 | 2020-07-28 | Ачиллион Фармасьютикалс, Инк. | Хиназолиновые и индольные соединения для лечения медицинских нарушений |
EP3841086A4 (en) | 2018-08-20 | 2022-07-27 | Achillion Pharmaceuticals, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D |
EP3866773A4 (en) | 2018-10-16 | 2022-10-26 | Georgia State University Research Foundation, Inc. | CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL CONDITIONS |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
US4329451A (en) * | 1980-11-03 | 1982-05-11 | The Dow Chemical Company | Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative |
JPS57171428A (en) * | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
LU86099A1 (fr) * | 1985-09-30 | 1987-04-02 | Pharlyse | Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant |
US5051261A (en) * | 1987-11-24 | 1991-09-24 | Fmc Corporation | Method for preparing a solid sustained release form of a functionally active composition |
CA1334379C (en) * | 1987-11-24 | 1995-02-14 | James William Mcginity | Method for preparing a solid sustained release form of a functionally active composition |
US4835188A (en) * | 1987-12-08 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
US5326572A (en) * | 1989-03-23 | 1994-07-05 | Fmc Corporation | Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions |
EP0421582A1 (en) * | 1989-10-03 | 1991-04-10 | Warner-Lambert Company | Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and method for preparing same |
JPH03232814A (ja) * | 1990-02-08 | 1991-10-16 | Shin Etsu Chem Co Ltd | 徐放性錠剤の製造方法 |
JP2915590B2 (ja) * | 1991-02-15 | 1999-07-05 | 第一製薬株式会社 | マスクされた粒状物 |
ES2111065T5 (es) * | 1991-04-16 | 2005-06-16 | Nippon Shinyaku Company, Limited | Procedimiento para producir una dispersion solida. |
DE4244466C2 (de) * | 1992-12-24 | 1995-02-23 | Pharmatech Gmbh | Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten |
-
1995
- 1995-12-18 US US08/849,457 patent/US5858411A/en not_active Expired - Lifetime
- 1995-12-18 PT PT95940461T patent/PT797987E/pt unknown
- 1995-12-18 TW TW084113515A patent/TW406022B/zh not_active IP Right Cessation
- 1995-12-18 JP JP51966196A patent/JP3893439B2/ja not_active Expired - Fee Related
- 1995-12-18 EP EP95940461A patent/EP0797987B1/en not_active Expired - Lifetime
- 1995-12-18 CN CN95196885A patent/CN1093758C/zh not_active Expired - Fee Related
- 1995-12-18 DK DK95940461T patent/DK0797987T3/da active
- 1995-12-18 ES ES95940461T patent/ES2210321T3/es not_active Expired - Lifetime
- 1995-12-18 WO PCT/JP1995/002594 patent/WO1996019200A1/ja active IP Right Grant
- 1995-12-18 KR KR1019970703851A patent/KR100424931B1/ko not_active IP Right Cessation
- 1995-12-18 AT AT95940461T patent/ATE251896T1/de not_active IP Right Cessation
- 1995-12-18 DE DE69531957T patent/DE69531957T2/de not_active Expired - Lifetime
-
1997
- 1997-06-18 NO NO19972814A patent/NO320356B1/no not_active IP Right Cessation
- 1997-06-18 FI FI972622A patent/FI119720B/fi active IP Right Grant
-
1998
- 1998-06-11 US US09/095,661 patent/US6030644A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0797987B1 (en) | 2003-10-15 |
NO972814L (no) | 1997-08-18 |
WO1996019200A1 (fr) | 1996-06-27 |
ATE251896T1 (de) | 2003-11-15 |
US5858411A (en) | 1999-01-12 |
TW406022B (en) | 2000-09-21 |
FI972622A (fi) | 1997-06-18 |
JP3893439B2 (ja) | 2007-03-14 |
CN1093758C (zh) | 2002-11-06 |
EP0797987A4 (en) | 1998-09-09 |
NO320356B1 (no) | 2005-11-28 |
PT797987E (pt) | 2004-02-27 |
FI972622A0 (fi) | 1997-06-18 |
NO972814D0 (no) | 1997-06-18 |
EP0797987A1 (en) | 1997-10-01 |
KR100424931B1 (ko) | 2004-07-05 |
CN1170357A (zh) | 1998-01-14 |
ES2210321T3 (es) | 2004-07-01 |
FI119720B (fi) | 2009-02-27 |
US6030644A (en) | 2000-02-29 |
DE69531957T2 (de) | 2004-08-12 |
DE69531957D1 (de) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0797987T3 (da) | Granulært præparat med langvarig frigivelse og fremgangsmåde til fremstilling deraf | |
NZ239802A (en) | A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production | |
HUT59005A (en) | Process for producing transdermal pharmaceutical preparations containing 2-amino-6-(propyl-amino)-4,5,6,7-tetrahydro-benzothiazole | |
CA2229266A1 (en) | Polyaluminum chlorides and polyaluminum chlorosulfates methods and compositions | |
HUT62784A (en) | Process for producing pharmaceutical compositions of elongated release, with ph-controlled membrane | |
DE59305700D1 (de) | Verfahren zur Herstellung von festen pharmazeutischen Retardformen | |
HUP9903647A2 (hu) | Vizes oldatban újra diszpergálható polimer por | |
TW270085B (da) | ||
ATE80298T1 (de) | Dispergierbare, cimetidin enthaltende tabletten. | |
CA2017851A1 (en) | Micronised biodegradable particles, process for preparing them and the use thereof | |
EP0606930A3 (en) | Process for preparation of polymer particles, process for preparation of toner particles and particles prepared according to these processes. | |
DK0834314T3 (da) | Granuler der indeholder pranlukast, fremgangsmåde til fremstilling af granulerne, og fremgangsmåde til reduktion af pranlukasts klæbeevne | |
UA60352C2 (uk) | Синтетичні полісахариди та фармацевтична композиція, що їх містить | |
GR3015052T3 (en) | Antibiotic GE 2270 factors A1, A2, A3 and H. | |
CA2207334A1 (en) | Sustained-release granular preparations and production process thereof | |
HUT60509A (en) | Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan | |
FR2689876B1 (fr) | Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine. | |
EP0480391A3 (en) | Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions | |
CS39189A2 (en) | Method of tetrahydropyridine derivatives production | |
KR890012940A (ko) | 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논, 이의 제조방법 및 치료적 용도 | |
KR930001932A (ko) | 정화제 겸 탈취제의 제조방법 | |
RU96101270A (ru) | Способ лечения аллергодерматозов у детей |